VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Pulse/Companies/Compare
Assort Health
VS
Celea Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

AH
Assort Health

Assort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.

2 Pulse stories
CT
Celea Therapeutics

Clinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopathic pulmonary fibrosis, spun out of PureTech Health.

4 Pulse stories
Total Raised
$222M
$180M
Assort HealthCelea Therapeutics
Last Valuation
$1.2B
Assort HealthCelea Therapeutics
Biotech
Sector
Biotech
2023
Founded
2025
San Francisco, California
HQ
Boston, MA
Private
Status
Private
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Celea Therapeutics investors
RA Capital ManagementLeaps by BayerPureTech Health

Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Celea Therapeutics.

@Trace_Cohen·t@nyvp.com